Levoketoconazole Patent Expiration
Levoketoconazole is used for treating Cushing's syndrome in patients with endogenous hypercortisolemia, when surgery is not an option or has not been curative. It was first introduced by Strongbridge Dublin Ltd
Levoketoconazole Patents
Given below is the list of patents protecting Levoketoconazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Recorlev | US11020393 | Methods of treating disease with levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US11278547 | Methods of treating disease with levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US11903940 | Methods of treating disease with levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US10098877 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Jan 10, 2026 | Strongbridge |
| Recorlev | US10517868 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Jan 10, 2026 | Strongbridge |
| Recorlev | US10835530 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Jan 10, 2026 | Strongbridge |
| Recorlev | US11478471 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Jan 10, 2026 | Strongbridge |
| Recorlev | US9918984 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Jan 10, 2026 | Strongbridge |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Levoketoconazole's patents.
Latest Legal Activities on Levoketoconazole's Patents
Given below is the list recent legal activities going on the following patents of Levoketoconazole.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 06 May, 2024 | US10835530 |
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US9918984 |
| Patent Issue Date Used in PTA Calculation Critical | 20 Feb, 2024 | US11903940 |
| Recordation of Patent eGrant | 20 Feb, 2024 | US11903940 |
| Recordation of Patent Grant Mailed Critical | 20 Feb, 2024 | US11903940 |
| Mail Patent eGrant Notification | 20 Feb, 2024 | US11903940 |
| Patent eGrant Notification | 20 Feb, 2024 | US11903940 |
| Email Notification Critical | 20 Feb, 2024 | US11903940 |
| Email Notification Critical | 01 Feb, 2024 | US11903940 |
| Issue Notification Mailed Critical | 31 Jan, 2024 | US11903940 |
Levoketoconazole's Family Patents
